BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32075737)

  • 1. CD32
    Darcis G; Kootstra NA; Hooibrink B; van Montfort T; Maurer I; Groen K; Jurriaans S; Bakker M; van Lint C; Berkhout B; Pasternak AO
    Cell Rep; 2020 Feb; 30(7):2284-2296.e3. PubMed ID: 32075737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.
    Martin GE; Pace M; Thornhill JP; Phetsouphanh C; Meyerowitz J; Gossez M; Brown H; Olejniczak N; Lwanga J; Ramjee G; Kaleebu P; Porter K; Willberg CB; Klenerman P; Nwokolo N; Fox J; Fidler S; Frater J
    Front Immunol; 2018; 9():928. PubMed ID: 29780387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD32
    Noto A; Procopio FA; Banga R; Suffiotti M; Corpataux JM; Cavassini M; Riva A; Fenwick C; Gottardo R; Perreau M; Pantaleo G
    J Virol; 2018 Oct; 92(20):. PubMed ID: 29976671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.
    Descours B; Petitjean G; López-Zaragoza JL; Bruel T; Raffel R; Psomas C; Reynes J; Lacabaratz C; Levy Y; Schwartz O; Lelievre JD; Benkirane M
    Nature; 2017 Mar; 543(7646):564-567. PubMed ID: 28297712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.
    Abdel-Mohsen M; Kuri-Cervantes L; Grau-Exposito J; Spivak AM; Nell RA; Tomescu C; Vadrevu SK; Giron LB; Serra-Peinado C; Genescà M; Castellví J; Wu G; Del Rio Estrada PM; González-Navarro M; Lynn K; King CT; Vemula S; Cox K; Wan Y; Li Q; Mounzer K; Kostman J; Frank I; Paiardini M; Hazuda D; Reyes-Terán G; Richman D; Howell B; Tebas P; Martinez-Picado J; Planelles V; Buzon MJ; Betts MR; Montaner LJ
    Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Latent Human Immunodeficiency Virus (HIV) Reservoir Resides Primarily in CD32-CD4+ T Cells in Perinatally HIV-Infected Adolescents With Long-Term Virologic Suppression.
    Dhummakupt A; Siems LV; Singh D; Chen YH; Anderson T; Collinson-Streng A; Zhang H; Patel P; Agwu A; Persaud D
    J Infect Dis; 2019 Jan; 219(1):80-88. PubMed ID: 30053296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
    Badia R; Ballana E; Castellví M; García-Vidal E; Pujantell M; Clotet B; Prado JG; Puig J; Martínez MA; Riveira-Muñoz E; Esté JA
    Nat Commun; 2018 Jul; 9(1):2739. PubMed ID: 30013105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4
    Grau-Expósito J; Serra-Peinado C; Miguel L; Navarro J; Curran A; Burgos J; Ocaña I; Ribera E; Torrella A; Planas B; Badía R; Castellví J; Falcó V; Crespo M; Buzon MJ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD32 is enriched on CD4dimCD8bright T cells.
    Virdi AK; Wallace J; Barbian H; Richards MH; Ritz EM; Sha B; Al-Harthi L
    PLoS One; 2020; 15(9):e0239157. PubMed ID: 32960910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
    Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
    J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy.
    Sun H; Kim D; Li X; Kiselinova M; Ouyang Z; Vandekerckhove L; Shang H; Rosenberg ES; Yu XG; Lichterfeld M
    J Virol; 2015 Nov; 89(22):11284-93. PubMed ID: 26339043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
    Hermankova M; Siliciano JD; Zhou Y; Monie D; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
    J Virol; 2003 Jul; 77(13):7383-92. PubMed ID: 12805437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype.
    Thornhill JP; Pace M; Martin GE; Hoare J; Peake S; Herrera C; Phetsouphanh C; Meyerowitz J; Hopkins E; Brown H; Dunn P; Olejniczak N; Willberg C; Klenerman P; Goldin R; Fox J; Fidler S; Frater J;
    Mucosal Immunol; 2019 Sep; 12(5):1212-1219. PubMed ID: 31239514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited HIV-1 Reactivation in Resting CD4
    Kumar A; Abbas W; Bouchat S; Gatot JS; Pasquereau S; Kabeya K; Clumeck N; De Wit S; Van Lint C; Herbein G
    Sci Rep; 2016 Dec; 6():38313. PubMed ID: 27922055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct gene expression by expanded clones of quiescent memory CD4
    Weymar GHJ; Bar-On Y; Oliveira TY; Gaebler C; Ramos V; Hartweger H; Breton G; Caskey M; Cohn LB; Jankovic M; Nussenzweig MC
    Cell Rep; 2022 Sep; 40(10):111311. PubMed ID: 36070690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control.
    García M; Navarrete-Muñoz MA; Ligos JM; Cabello A; Restrepo C; López-Bernaldo JC; de la Hera FJ; Barros C; Montoya M; Fernández-Guerrero M; Estrada V; Górgolas M; Benito JM; Rallón N
    Sci Rep; 2018 Oct; 8(1):15541. PubMed ID: 30341387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
    J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.